Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ACSS2-IN-2
Cat. No.:
OB0225LY-0012
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
ACSS2-IN-2 is an inhibitor of acetyl-CoA synthetase short-chain family member 2 (ACSS2). It selectively inhibits ACSS2 activity, which plays a role in lipid metabolism.
Synonym:
2332820-04-7; Acss2 inhibitor 261; Methyl 3-[4-[[3-(1,1-difluoroethyl)phenyl]carbamoyl]-3-methyl-5-oxo-4H-pyrazol-1-yl]benzoate; Benzoic acid, 3-[4-[[[3-(1,1-difluoroethyl)phenyl]amino]carbonyl]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-, methyl ester
CAS No.:
2332820-04-7
Compound CID:
139443008
Formula:
C21H19F2N3O4
Formula Weight:
415.39
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
ACSS2-IN-2 can be used to study viral infections, metabolic disorders, neurodegenerative diseases, inflammatory/autoimmune conditions, and cancer.
Library Information
Targets:
Lipid metabolism; Fatty acid synthesis
Receptors:
ACSS2
Pathways:
Metabolism
Plate Number:
AOCL-1
Plate Location:
b3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
90 mg/mL; 216.7 mM
